Darren D. O’Rielly

1.1k total citations
43 papers, 694 citations indexed

About

Darren D. O’Rielly is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Darren D. O’Rielly has authored 43 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 22 papers in Immunology and 15 papers in Hematology. Recurrent topics in Darren D. O’Rielly's work include Spondyloarthritis Studies and Treatments (18 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Autoimmune and Inflammatory Disorders Research (15 papers). Darren D. O’Rielly is often cited by papers focused on Spondyloarthritis Studies and Treatments (18 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Autoimmune and Inflammatory Disorders Research (15 papers). Darren D. O’Rielly collaborates with scholars based in Canada, United States and United Kingdom. Darren D. O’Rielly's co-authors include Proton Rahman, Christopher W. Loomis, Nicole M. Roslin, Joseph Beyene, Michael P. Hefferan, Mohammed Uddin, Meghna Jani, James T. Elder, Vinod Chandran and C. W. Loomis and has published in prestigious journals such as PLoS ONE, Scientific Reports and Neuroscience.

In The Last Decade

Darren D. O’Rielly

41 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darren D. O’Rielly Canada 15 351 321 175 122 122 43 694
Rossella Gulli Italy 14 157 0.4× 134 0.4× 62 0.4× 180 1.5× 61 0.5× 21 676
Queenie Lai Kwan Lam Hong Kong 10 330 0.9× 113 0.4× 47 0.3× 81 0.7× 148 1.2× 12 763
L Iversen Denmark 14 237 0.7× 227 0.7× 52 0.3× 350 2.9× 72 0.6× 28 718
Linlin Wan China 10 359 1.0× 230 0.7× 35 0.2× 144 1.2× 32 0.3× 36 699
Masaki Tokunaga Japan 9 226 0.6× 311 1.0× 42 0.2× 49 0.4× 47 0.4× 28 613
Xiaomin Lin China 14 189 0.5× 259 0.8× 101 0.6× 151 1.2× 35 0.3× 30 686
T. Okano Japan 10 144 0.4× 114 0.4× 54 0.3× 136 1.1× 48 0.4× 36 422
Sarah L. Spain United Kingdom 14 395 1.1× 79 0.2× 38 0.2× 279 2.3× 128 1.0× 17 893
Kenzo Muramoto Japan 11 387 1.1× 79 0.2× 59 0.3× 108 0.9× 46 0.4× 19 720
Jakob Triebel Germany 15 84 0.2× 136 0.4× 174 1.0× 184 1.5× 55 0.5× 50 770

Countries citing papers authored by Darren D. O’Rielly

Since Specialization
Citations

This map shows the geographic impact of Darren D. O’Rielly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren D. O’Rielly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren D. O’Rielly more than expected).

Fields of papers citing papers by Darren D. O’Rielly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren D. O’Rielly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren D. O’Rielly. The network helps show where Darren D. O’Rielly may publish in the future.

Co-authorship network of co-authors of Darren D. O’Rielly

This figure shows the co-authorship network connecting the top 25 collaborators of Darren D. O’Rielly. A scholar is included among the top collaborators of Darren D. O’Rielly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren D. O’Rielly. Darren D. O’Rielly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roslin, Nicole M., Daniel Vincent, Pascale Marquis, et al.. (2023). Highly variable hearing loss due to POU4F3 (c.37del) is revealed by longitudinal, frequency specific analyses. European Journal of Human Genetics. 31(7). 815–823. 1 indexed citations
2.
O’Rielly, Darren D. & Proton Rahman. (2021). Clinical and molecular significance of genetic loci associated with psoriatic arthritis. Best Practice & Research Clinical Rheumatology. 35(2). 101691–101691. 7 indexed citations
3.
Rahmati, Sara, Lam C. Tsoi, Darren D. O’Rielly, Vinod Chandran, & Proton Rahman. (2020). Complexities in Genetics of Psoriatic Arthritis. Current Rheumatology Reports. 22(4). 10–10. 18 indexed citations
4.
Rahmati, Sara, Darren D. O’Rielly, Quan Li, et al.. (2020). Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis. Scientific Reports. 10(1). 21703–21703. 9 indexed citations
5.
Green, Jane S., et al.. (2020). The genetic architecture of Stargardt macular dystrophy (STGD1): a longitudinal 40-year study in a genetic isolate. European Journal of Human Genetics. 28(7). 925–937. 10 indexed citations
6.
O’Rielly, Darren D., Meghna Jani, Proton Rahman, & James T. Elder. (2019). The Genetics of Psoriasis and Psoriatic Arthritis. The Journal of Rheumatology. 95. 46–50. 40 indexed citations
7.
Green, Jane, Darren D. O’Rielly, Bridget A. Fernandez, et al.. (2019). Novel Usher syndrome pathogenic variants identified in cases with hearing and vision loss. BMC Medical Genetics. 20(1). 68–68. 9 indexed citations
8.
O’Rielly, Darren D., et al.. (2018). A Review of Ustekinumab in the Treatment of Psoriatic Arthritis. Immunotherapy. 10(5). 361–372. 13 indexed citations
9.
O’Rielly, Darren D. & Proton Rahman. (2018). A review of ixekizumab in the treatment of psoriatic arthritis. Expert Review of Clinical Immunology. 14(12). 993–1002. 12 indexed citations
10.
Mital, Seema, Darren D. O’Rielly, Huy Nguyen, & Proton Rahman. (2018). FRI0634 Cost savings of using hla-b*27 tag snp genotyping to determine hla-b*27 status in a canadian population. Annals of the Rheumatic Diseases. 77. 839–840. 1 indexed citations
11.
O’Rielly, Darren D., et al.. (2018). Ustekinumab in psoriatic arthritis and related phenotypes. Therapeutic Advances in Chronic Disease. 9(10). 191–198. 16 indexed citations
12.
Winchester, Robert, Darren D. O’Rielly, & Proton Rahman. (2018). Genetics of psoriatic arthritis. Oxford University Press eBooks. 4 indexed citations
13.
Stanton, Susan G., et al.. (2016). A common variant in CLDN14 causes precipitous, prelingual sensorineural hearing loss in multiple families due to founder effect. Human Genetics. 136(1). 107–118. 11 indexed citations
14.
Uddin, Mohammed, et al.. (2015). Integrated Genomics Identifies Convergence of Ankylosing Spondylitis with Global Immune Mediated Disease Pathways. Scientific Reports. 5(1). 10314–10314. 18 indexed citations
15.
O’Rielly, Darren D. & Proton Rahman. (2015). Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis. Rheumatic Disease Clinics of North America. 41(4). 623–642. 51 indexed citations
16.
Peddle, Lynette, et al.. (2011). Genome-Wide Signatures of ‘Rearrangement Hotspots’ within Segmental Duplications in Humans. PLoS ONE. 6(12). e28853–e28853. 7 indexed citations
17.
Bruno, Damien L., Zornitza Stark, David J. Amor, et al.. (2011). Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high-resolution SNP microarrays. Human Mutation. 32(12). 1500–1506. 32 indexed citations
18.
O’Rielly, Darren D., et al.. (2009). TNF-α −308 G/A polymorphism and responsiveness to TNF-α blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. The Pharmacogenomics Journal. 9(3). 161–167. 72 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026